Profit Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Profit Investment Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-36,631	Closed	-$1.28M	–	90
2021 Q2	$1.28M	Hold	36,631	–	–	0.68%	41
2021 Q1	$1.49M	Sell	36,631 -5,565	-13%	-$256K	0.85%	38
2020 Q4	$1.83M	Hold	42,196	–	–	1.17%	34
2020 Q3	$2.33M	Buy	42,196 +2,434	+6%	+$155K	1.44%	27
2020 Q2	$2.51M	Sell	39,762 -7,111	-15%	-$488K	1.75%	20
2020 Q1	$2.4M	Hold	46,873	–	–	2.24%	13
2019 Q4	$3.73M	Buy	46,873 +20,697	+79%	+$1.23M	2.5%	8
2019 Q3	$1.27M	Buy	+26,176	New	+$1.36M	0.91%	48

Other funds holding GBT

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Profit Investment Management's GBT Position: Q3 2021 in Review

Profit Investment Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2021, closing a stake of 36,631 shares — an estimated $1.28M sold.

Profit Investment Management first reported a position in GBT in Q3 2019 and held it in 8 quarters. The position peaked at $3.73M in Q4 2019. 187 funds tracked by Wall St. Rank hold GBT as of Q3 2021.

Profit Investment Management reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
Profit Investment Management sold 36,631 Global Blood Therapeutics, Inc. shares in Q3 2021, an estimated $1.28M.
Profit Investment Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2019 and held it in 8 quarters.
Profit Investment Management's Global Blood Therapeutics, Inc. position peaked at $3.73M in Q4 2019.
187 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2021.

Based on Profit Investment Management's 13F filing for Q3 2021, filed 8 Oct 2021.